OClawVPS.com
Immunophotonics, Inc.
Edit

Immunophotonics, Inc.

http://www.immunophotonics.com/
Last activity: 24.02.2026
Active
Categories: BioTechDrugHealthTechITLocal
INTERVENTIONAL IMMUNO-ONCOLOGY
Mentions
23
Location: United States, Missouri, Saint Louis
Total raised: $23.9M

Investors 7

Funding Rounds 2

DateSeriesAmountInvestors
25.10.2022Grant$2.5M-
06.04.2022-$21.4M-

Mentions in press and media 23

DateTitleDescription
24.02.2026Immunophotonics Secures European Patent Protecting Use of Lead Asset in Combination with Checkpoint InhibitorsAdditional intellectual property protection reinforces the strategic value of IP-001 and supports ongoing clinical development efforts. SAINT LOUIS, MO, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- Immunophotonics, Inc., a clinica...
15.04.2025Jacqueline Hess Joins Immunophotonics Board of DirectorsST. LOUIS, MO, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on immuno-oncology, is pleased to announce the appointment of Jacqueline Hess to its Board of Directors. With...
13.09.2024Immunophotonics, CIRSE, and Next Research Announce Innovative Phase 2/3 Clinical Trial: INJECTABL-3ST. LOUIS, MO, UNITED STATES, September 13, 2024 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biopharma company developing novel immune-stimulating drugs to augment routine tumor destruction techniques – such as tumor ablat...
15.08.2024Immunophotonics Announces 1st Patient Dosed in a Randomized Phase 2 Study at the University of LouisvilleSAINT LOUIS, MISSOURI, USA, August 15, 2024 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, in collaboration with Dr. Robert CG Martin ...
26.06.2024Envisioning a future where food is synonymous with health, fostering longevity, productivity, and societal well-beingIf you missed Carter’s testimony at the Senate hearing, “Feeding a Healthier America: Current Efforts and Potential Opportunities for Food is Medicine,” the replay is available here. The hearing emphasized the importance of nutrition to red...
27.02.2024AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of ImmunotherapyLATHAM, NEW YORK, February 27, 2024 /EINPresswire.com/ -- AngioDynamics, Inc. (NASDAQ: ANGO), a global provider of medical devices, and Immunophotonics, Inc., a clinical-stage biopharma company focused on immuno-oncology, are pleased to ann...
12.07.2023Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in GermanyST. LOUIS, MISSOURI, July 12, 2023/EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its f...
31.05.2023Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in the United KingdomSAINT LOUIS, MISSOURI, AND BERN SWITZERLAND, May 31, 2023/EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment ...
16.05.2023Immunophotonics Receives Green Light from FDA to Open Investigational New Drug (IND) Study for IP-001 in the U.S.ST. LOUIS, MISSOURI, USA, May 16, 2023/EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel innate immune stimulating drugs with antigen depot properties, has announc...
24.01.2023Immunophotonics Announces 1st Patient Dosed in IP-IIO-622 Phase 1b/2a Clinical Trial in Advanced Solid Tumor IndicationsSAINT LOUIS, MISSOURI, USA, January 24, 2023 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the initiation of recruitmen...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In